Investor Relations

Corporate profile

Sequenom, Inc. (NASDAQ: SQNM) is committed to enabling healthier lives through the development of innovative products and services. The company serves patients and physicians by providing early patient management information.

Corporate Update March 2015
Click to download

Click to download

Company presentations
Upcoming webcasts
Wednesday, March 4, 2015
2:00pm PST
Contact us
Sequenom, Inc.
Donna Nichols
Investor Relations
858-202-9028
investorrelations@sequen...
Communication with the board of directors

Persons interested in communicating with our Board of Directors regarding their concerns or issues may send written correspondence to the Board of Directors in care of the Secretary at Sequenom, Inc., 3595 John Hopkins Court, San Diego, California 92121 or by email to board@sequenom.com. The Secretary will screen communications for spam, junk mail, mass mailings, product complaints, product inquiries, new product suggestions, resumes, job inquiries, surveys, business solicitations and advertisements, as well as unduly hostile, threatening, illegal, unsuitable, frivolous, patently offensive or otherwise inappropriate material before forwarding to the Board of Directors.


Price data
NASDAQSQNM